TTD | Drug: D0S5BV

Drug General Information
Drug ID	D0S5BV
Former ID	DNCL001605
Drug Name	ABT-652
Indication	Diabetic neuropathy; Musculoskeletal pain [ICD9: 250, 250.6, 356.0, 356.8, 338, 780; ICD10:E11.40, R52, G89]		Phase 2	[523180]
Company	Abbott Laboratories
Target and Pathway
Target(s)	Histamine H3 receptor	Target Info	Modulator	[549101]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Histamine receptors
Reactome	G alpha (i) signalling events
WikiPathways	Monoamine Transport
	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 523180	ClinicalTrials.gov (NCT01207115) A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee. U.S. National Institutes of Health.
Ref 549101	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032225)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information